{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1194.973","value":"0.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"144"}],"units":"Participants"}],"title":"C1D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"53.602","value":"31.49"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"135"}],"units":"Participants"}],"title":"C1D8"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"54.764","value":"57.89"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"126"}],"units":"Participants"}],"title":"C1D15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"57.666","value":"84.82"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"126"}],"units":"Participants"}],"title":"C1D22"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"60.155","value":"89.09"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"138"}],"units":"Participants"}],"title":"C2D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"61.167","value":"89.35"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"121"}],"units":"Participants"}],"title":"C2D15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"76.469","value":"64.15"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"131"}],"units":"Participants"}],"title":"C3D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"78.406","value":"91.73"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"109"}],"units":"Participants"}],"title":"C3D15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"70.062","value":"86.05"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"118"}],"units":"Participants"}],"title":"C4D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"68.035","value":"105.42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"108"}],"units":"Participants"}],"title":"C4D15"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"65.275","value":"106.08"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"108"}],"units":"Participants"}],"title":"C5D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"64.985","value":"111.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"107"}],"units":"Participants"}],"title":"C6D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"60.017","value":"134.14"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"96"}],"units":"Participants"}],"title":"C7D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"55.946","value":"146.15"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"86"}],"units":"Participants"}],"title":"C8D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"65.193","value":"162.84"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"82"}],"units":"Participants"}],"title":"C9D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"60.719","value":"145.86"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"}],"units":"Participants"}],"title":"C10D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"56.078","value":"169.39"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"71"}],"units":"Participants"}],"title":"C11D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"56.814","value":"182.32"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"63"}],"units":"Participants"}],"title":"C12D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"54.667","value":"215.85"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"}],"units":"Participants"}],"title":"C13D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"55.172","value":"214.88"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"title":"C14D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"58.885","value":"253.61"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"}],"units":"Participants"}],"title":"C15D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"50.965","value":"206.60"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"}],"units":"Participants"}],"title":"C16D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"45.364","value":"242.79"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"}],"units":"Participants"}],"title":"C17D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"58.273","value":"216.70"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"}],"units":"Participants"}],"title":"C18D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"42.099","value":"240.36"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"title":"C19D1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"164.07"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"title":"C20D1"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"136.883","value":"9.51"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"}],"units":"Participants"}],"title":"EOT"}],"denoms":[{"counts":[{"groupId":"OG000","value":"149"}],"units":"Participants"}],"description":"Trough Concentration (Ctrough) is the concentration prior to study drug administration.","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Participants received isatuximab 10 mg/kg IV infusion on Days 1, 8, 15, and 22 at Cycle 1, and then on Days 1 and 15 of subsequent cycles plus pomalidomide 4 mg PO on Days 1 to 21 of each 28-day treatment cycle and dexamethasone 40 mg (participants \\>= 75 years of age received 20 mg dexamethasone), PO or IV on Day 1, 8, 15, 22 of each 28-day treatment cycle until disease progression or unacceptable toxicity or participant's wish to discontinue study treatment, or any other reason, whichever comes first (maximum exposure: 76.7 weeks).","id":"OG000","title":"IPd (Isatuximab + Pomalidomide + Dexamethasone)"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Analysis was performed on PK population. Here, 'Number analyzed' = participants with available data for each specified category. Data for this OM was not planned to be collected and analyzed for Pd arm.","reportingStatus":"POSTED","timeFrame":"Pre-infusion on C1D1, C1D8, C1D15, C1D22, C2D1, C2D15, C3D1, C3D15, C4D1, C4D15, C5D1, C6D1, C7D1, C8D1, C9D1, C10D1, C11D1, C12D1, C13D1, C14D1, C15D1, C16D1, C17D1, C18D1, C19D1, C20D1; End of treatment (EOT [30 days after last drug administration])","title":"PK Parameter: Plasma Concentration of Isatuximab at Ctrough","type":"SECONDARY","unitOfMeasure":"mcg/mL"}